Towards Healthcare
RNAi Therapeutics Market
Updated Date: 01 November 2025   |   Report Code: 5115
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

RNAi Therapeutics Market Size & Gene Silencing for Targeted Treatment

Market insights predict the global RNAi therapeutics industry will increase from USD 1.28 billion in 2024 to USD 5.11 billion by 2034, achieving a CAGR of 14.9%. In 2023, siRNA therapy dominated with a 64% market share, leading the RNA-based treatment space. Cancer remained the top focus, with oncology applications expected to stay ahead in the coming years. North America led the market, holding a 41% share, highlighting strong regional adoption and investment.

Last Updated : 01 November 2025 Category: Biotechnology Insight Code: 5115 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global RNAi Therapeutics Market Assessment

  • Overview
  • Global RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • siRNA
    • miRNA
  • Global RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology
    • Cardiovascular Disease
    • Infectious Disease
    • Diabetes
    • Neurology
    • Other Applications
  • Global RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs
  • Global RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

North America RNAi Therapeutics Market Assessment

  • Overview
  • North America RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • siRNA
    • miRNA
  • North America RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology
    • Cardiovascular Disease
    • Infectious Disease
    • Diabetes
    • Neurology
    • Other Applications
  • North America RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Europe RNAi Therapeutics Market Assessment

  • Overview
  • Europe RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • siRNA
    • miRNA
  • Europe RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology
    • Cardiovascular Disease
    • Infectious Disease
    • Diabetes
    • Neurology
    • Other Applications
  • Europe RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Asia Pacific RNAi Therapeutics Market Assessment

  • Overview
  • Asia Pacific RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • siRNA
    • miRNA
  • Asia Pacific RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology
    • Cardiovascular Disease
    • Infectious Disease
    • Diabetes
    • Neurology
    • Other Applications
  • Asia Pacific RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Latin America RNAi Therapeutics Market Assessment

  • Overview
  • Latin America RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • siRNA
    • miRNA
  • Latin America RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology
    • Cardiovascular Disease
    • Infectious Disease
    • Diabetes
    • Neurology
    • Other Applications
  • Latin America RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Middle East and Africa RNAi Therapeutics Market Assessment

  • Overview
  • Middle East and Africa RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • siRNA
    • miRNA
  • Middle East and Africa RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Oncology
    • Cardiovascular Disease
    • Infectious Disease
    • Diabetes
    • Neurology
    • Other Applications
  • Middle East and Africa RNAi Therapeutics Market Size Value (US$) and Volume (Billion Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Company Profiles

  • Alnylam Pharmaceuticals, Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Novartis
  • Arbutus Biopharma
  • Arrowhead Pharmaceuticals
  • Novo Nordisk (Dicerna Pharmaceuticals)
  • Sirnaomics

Conclusion & Recommendations

FAQ's

Answer : RNAi therapeutics use small RNA molecules to target and silence specific genes involved in disease progression, offering potential therapies for various diseases, including cancer, genetic disorders, and viral infections.

Answer : North America leads the RNAi therapeutics market, with a significant presence of biopharmaceutical companies, robust research infrastructure, and supportive regulatory frameworks driving innovation and commercialization efforts.

Answer : National Institute of Health, World Health Organization, Food and Drug Administration, American Cancer Society.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar